Stock comparison
Bausch Health Companies
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BHC
Bausch Health Companies
Market cap
$2.04B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BHC | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 77B | LMAT |
| Benjamin Graham | 18F | 89A | LMAT |
| Philip Fisher | 47D | 81C | LMAT |
| Peter Lynch | 17F | 67B | LMAT |
| Joel Greenblatt | 17F | 56D | LMAT |
| Charlie Munger | 56D | 68D | LMAT |
| Terry Smith | 49D | 69D | LMAT |
Side-by-side metrics
| Metric | BHC | LMAT |
|---|---|---|
| Market cap | $2.04B | $2.23B |
| P/E (TTM) | - | 37.1x |
| EV/EBIT | 9.7x | 36.6x |
| ROIC (TTM) | 11.59% | 9.43% |
| Gross margin | 61.67% | 72.39% |
| Net margin | -11.27% | 24.35% |
| Revenue CAGR 5y | 5.49% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | - | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BHC leads on
- Debt / Equity-vs 0.5x+105%
- P/E (TTM)-vs 37.1x+105%
- EV/EBIT9.7xvs 36.6x+74%
- ROIC (TTM)11.59%vs 9.43%+19%
LMAT leads on
- Net margin24.35%vs -11.27%+146%
- Dividend yield0.84%vs 0.0%+100%
- Revenue CAGR 5y12.75%vs 5.49%+57%
- Gross margin72.39%vs 61.67%+15%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.